Overview
Papillary intralymphatic angioendothelioma (PILA), also known as Dabska tumor or endovascular papillary angioendothelioma, is an extremely rare vascular tumor that arises from the cells lining lymphatic vessels. It is classified as a borderline (low-grade malignant) vascular tumor, meaning it has the potential to behave aggressively in some cases but generally follows a relatively indolent (slow-growing) course. The tumor most commonly appears as a painless, slow-growing mass in the skin or soft tissues, often in the arms or legs, though it can occur in other locations including the head, neck, spleen, or bone. PILA typically presents as a firm, bluish or reddish nodule under the skin that may gradually enlarge over weeks to months. In some cases, the overlying skin may appear discolored or swollen. The tumor can sometimes involve nearby lymph nodes, which is why careful evaluation is important after diagnosis. While distant spread (metastasis) is rare, local recurrence after removal has been reported in some patients. Treatment usually involves complete surgical removal of the tumor with clear margins. Because of its rarity, there is no standardized chemotherapy or radiation protocol, though these may be considered in cases where the tumor cannot be fully removed or has spread. Long-term follow-up with imaging and clinical examinations is recommended to watch for recurrence. The overall prognosis is generally favorable when the tumor is completely excised, though ongoing monitoring is important.
Also known as:
Key symptoms:
Painless lump or mass under the skinBluish or reddish skin discoloration over the massSlow-growing soft tissue swellingSwollen lymph nodes near the tumorFirm nodule in the arm or legLocalized skin thickeningOccasional tenderness at the tumor siteSwelling that does not go away on its own
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Papillary intralymphatic angioendothelioma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Papillary intralymphatic angioendothelioma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Papillary intralymphatic angioendothelioma.
Community
No community posts yet. Be the first to share your experience with Papillary intralymphatic angioendothelioma.
Start the conversation →Latest news about Papillary intralymphatic angioendothelioma
No recent news articles for Papillary intralymphatic angioendothelioma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Was the tumor completely removed with clear margins?,What is the risk of the tumor coming back, and how will we monitor for recurrence?,How often should follow-up imaging or examinations be scheduled?,Are there any signs or symptoms I should watch for that would require immediate attention?,Should I seek a second opinion from a specialist in rare vascular tumors?,Is there any role for additional treatment such as radiation or chemotherapy in my case?,Are there any clinical trials or research studies I could participate in?
Common questions about Papillary intralymphatic angioendothelioma
What is Papillary intralymphatic angioendothelioma?
Papillary intralymphatic angioendothelioma (PILA), also known as Dabska tumor or endovascular papillary angioendothelioma, is an extremely rare vascular tumor that arises from the cells lining lymphatic vessels. It is classified as a borderline (low-grade malignant) vascular tumor, meaning it has the potential to behave aggressively in some cases but generally follows a relatively indolent (slow-growing) course. The tumor most commonly appears as a painless, slow-growing mass in the skin or soft tissues, often in the arms or legs, though it can occur in other locations including the head, neck
How is Papillary intralymphatic angioendothelioma inherited?
Papillary intralymphatic angioendothelioma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Papillary intralymphatic angioendothelioma?
15 specialists and care centers treating Papillary intralymphatic angioendothelioma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.